Skip to content

Clinical trials

Sepsis trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sepsis Country / region: Hong Kong Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20082
20111
20192
20221
20231
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong3
The University of Hong Kong3
Belinda Howe1
Critical Biologics Corporation1
Eisai Inc.1
GlaxoSmithKline1
Hospital Authority, Hong Kong1
KK Women's and Children's Hospital1
National Taiwan University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sepsis13
Shock, Septic5
Infections3
Pneumonia3
Critical Illness2
Emergencies2
Inflammation2
Burns1
Febrile Neutropenia1
Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.